| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81afd7465ffba8139e557bd8c35b5eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate |
2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f32f1487e1fee6022d184cc7cdc38a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2f2d6533a230b37845f8eca09edd50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4b35379f5562f2cd7ba295e4ed2bb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19cf3353e167d550f1acd02328b69a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_899873f7fe1248a29b817d72e85b7465 |
| publicationDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200104160-A |
| titleOfInvention |
Pharmaceutical composition for treating or preventing lung cancer |
| abstract |
The present invention relates to a compound or a pharmaceutically acceptable salt thereof that can be usefully used in the treatment or prevention of lung cancer. In addition, the present invention relates to a pharmaceutical composition for treating or preventing lung cancer comprising the compound or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |